Search News

Corporate Industry Technology Medical Updates

heart failure

Corporate
MoyoAssist® Extra-VAD, a Promising Solution for Short-to-Medium-Term Ventricular Assist for China NMPA trial, Showcased at 4th Academic Annual Conference of CSBE 2023-06-17
Corporate
The Chinese Start-Up Advancing Life Support Tech 2023-03-30
Corporate
magAssist Revealed in MedTech Outlook's Top 10 MedTech Companies in APAC Region for 2022 2023-03-14
Technology
Professor Nianguo Dong of Wuhan Union Hospital Gives Speech Entitled “Clinical Experience with the MoyoAssist® Extracorporeal Ventricular Assist Device” 2023-01-06
Corporate
Highlights｜magAssist Invited to Join VBData’s Live Stream on The Future is Now a Reality! Percutaneous Ventricular Assist Devices Fast-tracked for Clinical Application 2022-12-12
Corporate
magAssist founder Dr. Po-Lin HSU, was selected as 2022 Most Influential Business Women——Future by FORTUNE China 2022-11-03
Corporate
Fortune China recently released its 2022 list of China's most socially impactful startups, and magAssist is on the list. 2022-08-06
Technology
magAssist is participating in 2022 EUMS-ISMCS joint conference. 2022-05-24
Corporate
magAssist selected as 2021 Suzhou Incubated Unicorn Company 2022-01-11
Medical Updates
Percutaneous Ventricular Assist Device Led by Academician Junbo Ge and Jointly Developed by CCI and magAssist Makes Significant Progress 2021-11-11

Tabs： pVAD, cardiogenic shock, external life support systems, ECMO devices, IABP, Bridge-to-recovery, cardiogenic shock treatment, MoyoAssist Extra-VAD, solid technology of artificial hearts, Awards,